Lifandis links the industry to a wealth of biological samples from the HUNT studies. It is the entry point to a unique set of biological samples and extensive clinical and longitudinal data based on the Norwegian population. By connecting industry to high quality biosamples, a comprehensive network of national health registries, and depth information about health and disease we offer unparalleled access to this population.
Lifandis advances disease understanding and leads to better healthcare products.
Lifandis is owned by the Norwegian University of Science and Technology, the Central Norway Health Authority and the Nord-Trøndelag County.
The company changed its name from Hunt Biosciences AS to Lifandis AS as of April 1, 2014.